Wyeth (WYE)

BUY
Pharmaceutical sector is trading at very low valuations. Good growth profile and good portfolio of drugs. Also don’t have the problem of patent expirations that Pfizer does.
BUY
All the major drug stocks are starting to act better. In this type of market, money moves from risky stocks to defensive stocks. A good place to be.
DON'T BUY
All the big pharma companies are taking out a lot of costs. The problem is the pipeline is pretty lean, visability is lean. Maybe a little bit of a short term trade up to reward them for the reduced cost structure. Not significant.
TOP PICK
Have great new pharmaceutical products they will bring into the market in the 2006/2012 timeframe. 14 X earnings and 2 1/2 percent yield. High quality.
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

Wyeth (WYE) Frequently Asked Questions

What is Wyeth stock symbol?

Wyeth is a OTC stock, trading under the symbol WYE (previously WYE-N on Stockchase) on the (). It is usually referred to as or WYE

Is Wyeth a buy or a sell?

In the last year, there was no coverage of Wyeth published on Stockchase.

Is Wyeth a good investment or a top pick?

Wyeth was recommended as a Top Pick by Brian Rogers on 2004-06-04. Read the latest stock experts ratings for Wyeth.

Why is Wyeth stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.

Is Wyeth worth watching?

In the last year, there was no coverage of Wyeth published on Stockchase.